Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
2.790
-0.300 (-9.71%)
At close: Nov 6, 2026, 4:00 PM EST
2.800
+0.010 (0.36%)
After-hours: Nov 6, 2026, 7:30 PM EST

Nephros Earnings Call Transcripts

Fiscal Year 2026

  • Q3 revenue grew 18% YoY to $5.6M, and 9M revenue rose 20% to $16.9M with higher net income and adjusted EBITDA. Record active sites and expanding service and non-healthcare applications support growth, while costs and mix pressured margins.

  • Record Q2 2026 revenue and net income were driven by broad-based growth in core products and services, aided by a one-time tariff refund. Service revenue nearly tripled, and new product launches are expected to drive future growth as market education and regulation increase.

  • Investor update

    Revenue grew 7% to $5.2M in Q1, driven by programmatic and service growth, while gross margin declined to 57% due to tariffs and mix. Strategic focus is on expanding into new verticals, leveraging technology and education, and building recurring revenue through services. Margin recovery is expected as tariffs expire.

  • Record Q1 revenue of $5.2M was driven by 23% programmatic growth, offsetting lower emergency response sales. Gross margin fell to 57% due to tariffs, currency, and product mix, but margin improvement is expected as lower tariffs take effect.

Fiscal Year 2025

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022